Avoiding a rise-and-fall ATMPs cycle

Adopting advanced therapies in Europe requires long-term oriented health and fiscal policies inspired by a clear vision of the future and supported by robust evidence. Without it, the biggest promise of new medicine will turn into the failure of policy makers and the nightmare of operators, industries, and citizens.